Scientists generate functional, transplantable B cells from mice

Scientists Generate Functional, Transplantable B Cells From Mice chapter is one from the Health and Medical Updates class, written just as our scripter Linda Norton immediately upon February 7, 2019, this post might want to search with that hastag cells, Functional, generate, mice, Scientists, transplantable. I'm glad to pleasant you plus providing the other paragraph in reference health as well as I always posting the paper routine.

1 Scientistsge.jpg

This figure illustrates the process by which researchers generated functional, transplantable B cells from mice. Credit: Momoko Yoshimoto

Functional B-1 cells derived from mouse embryonic stem cells are capable of long-term engraftment and secrete natural antibodies after transplantation in mice, researchers report February 7th in the journal Stem Cell Reports. Scientists are interested in B-1 cells generated from pluripotent stem cells because they could be tested as a therapeutic for a broad range of immunological disorders.

“It is still challenging to produce transplantable immune cells from mouse embryonic stem cells, so obtaining transplantable functional B-1 cells from mouse embryonic stem cells is a significant advance in the field,” says senior study author Momoko Yoshimoto of the Center for Stem Cell & Regenerative Medicine at the McGovern Medical School at UTHealth in Houston. “The take-home message is that a portion of immune cells may be replaced by cell therapies utilizing pluripotent stem cells in the future.”

Hematopoietic stem cells in the adult bone marrow—the soft, sponge-like tissue in the center of most bones—provide various blood cells throughout life. Hematopoietic stem cell transplants are now routinely used to treat patients with cancers and other disorders of the blood and immune systems. But with current in vitro methods, it is challenging to produce hematopoietic stem cells that recapitulate the properties of cells in living organisms without gene manipulation.

In particular, bone marrow transplantation may fail to reconstitute some immune cells called B-1 cells, which produce immunoglobulin M (IgM) antibodies—the first type of antibody the immune system makes to fight a new infection. In addition to patients who receive stem cell transplants, IgM deficiency also occurs in individuals with some cancers, autoimmune diseases, allergic diseases, and gastrointestinal diseases, increasing the risk for life-threatening infections.

In the new study, Yoshimoto and her colleagues demonstrated that functional, transplantable B-1 cells can be generated from mouse embryonic stem cells without gene modifications. The researchers overcame previous barriers preventing this feat by using high-quality cell lines to support B cell development. After being transplanted into recipient mice, stem cell-derived B progenitors matured into B-1 cells that were maintained for more than 6 months and secreted natural IgM antibodies.

“Producing functional B-1 progenitors in vitro from mouse embryonic stem cells is an important step to develop a cell therapy to provide natural IgM and innate B-1 cells that may not be provided by bone marrow transplantation,” Yoshimoto says.

In future studies, the researchers will attempt to generate B cells from human induced pluripotent stem cells, which may be used for cell therapy to treat patients with immunological disorders. “This is just a first step in a long process to translate our findings to humans,” Yoshimoto says.


Stem cell study offers clues for optimizing bone marrow transplants and more


More information:
Stem Cell Reports, Lin et al.: “Long-Term Engraftment of ESC-Derived B-1 Progenitor Cells Supports HSC-Independent Lymphopoiesis” http://www.cell.com/stem-cell-reports/fulltext/S2213-6711(19)30007-4 , DOI: 10.1016/j.stemcr.2019.01.006


Provided by
Cell Press

Citation:
Scientists generate functional, transplantable B cells from mice (2019, February 7)
retrieved 7 February 2019
from https://medicalxpress.com/news/2019-02-scientists-functional-transplantable-cells-mice.html

You maybe want to leaf through anothers post health just after our related chapter or you maybe want to check it just after favoured section, I always writting these health blogpost routine for suggest together with hint as well technique so manage our health moreover living those healthy lifestyle. That part is published over Linda Norton with these title Scientists Generate Functional, Transplantable B Cells From Mice.

Related posts of "Scientists generate functional, transplantable B cells from mice"

Swine fever outbreak spreads to five prefectures across Japan

Government health officials have reported an outbreak of swine fever in Japan that has spread over five prefectures, including Osaka. So far, over 6600 pigs have been culled in an attempt to slow the spread of the virus. Gorodenkof | Shutterstock In a statement, one agricultural ministry official stated that whilst China has been fighting...

HIV drug could treat Alzheimer’s, age-associated disorders

Lamivudine, a generic HIV/AIDS medication significantly reduces age-related inflammation in old mice by halting retrotransposon activity. Two weeks of treatment reduced the signs of chronic inflammation -- white blood cells stained pink amongst green fat cells -- in old mouse fat tissue. Credit: Sedivy Lab/Brown University A new study found that an HIV drug significantly...

Mental illness not to blame for gun violence study finds

Credit: CC0 Public Domain Counter to a lot of public opinion, having a mental illness does not necessarily make a person more likely to commit gun violence. According to a new study, a better indicator of gun violence was access to firearms. A study by researchers at The University of Texas Medical Branch at Galveston...

Generic version of popular asthma inhaler wins FDA approval

(HealthDay)—The first generic version of the widely used Advair Diskus inhaler for asthma and chronic obstructive pulmonary disease (COPD) has won U.S. Food and Drug Administration approval. This approval "is part of our longstanding commitment to advance access to lower cost, high-quality generic alternatives," said Dr. Janet Woodcock, director of the FDA's Center for Drug...

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.